0

    524661

    WELCURE

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    WELCURE DRUGS & PHARMACEUTICAL Share Price Today

    Investment Returns

    Over 1 Month -7.40% Over 3 Months -16.66% Over 6 Months -26.47% Over 1 Year -72.82%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    WELCURE DRUGS & PHARMACEUTICAL fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 30.90
    • P/E Ratio (TTM) -6.25
    • Beta 1.25
    • Book Value / share 0.78
    • Return on equity 3.81%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -49.86
    info icon alternate text

    WELCURE DRUGS & PHARMACEUTICAL Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.00
    Operating Expense 49.86
    Net Profit -49.86
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.40
    EBITDA -49.86
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.04
    Net Profit 1.07
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.13
    EBITDA 1.44
    Effective Tax Rate (%) 25.17
    Particulars SEP 2025 (Values in Cr)
    Revenue 65.62
    Operating Expense 54.26
    Net Profit 8.50
    Net Profit Margin (%) 12.95
    Earnings Per Share (EPS) 0.76
    EBITDA 11.36
    Effective Tax Rate (%) 25.17
    Particulars JUN 2025 (Values in Cr)
    Revenue 299.91
    Operating Expense 268.78
    Net Profit 23.30
    Net Profit Margin (%) 7.76
    Earnings Per Share (EPS) 2.07
    EBITDA 31.14
    Effective Tax Rate (%) 25.17
    Particulars MAR 2025 (Values in Cr)
    Revenue 21.21
    Operating Expense 20.58
    Net Profit 2.54
    Net Profit Margin (%) 11.97
    Earnings Per Share (EPS) 0.33
    EBITDA 2.55
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 365.54
    Operating Expense 372.49
    Net Profit -5.49
    Net Profit Margin (%) -1.50
    Earnings Per Share (EPS) -0.04
    EBITDA -5.47
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 24.55
    Operating Expense 23.68
    Net Profit 2.17
    Net Profit Margin (%) 8.83
    Earnings Per Share (EPS) 0.36
    EBITDA 2.78
    Effective Tax Rate (%) 21.94
    Particulars MAR 2024 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.27
    Net Profit -0.17
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.13
    EBITDA -0.13
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.14
    Net Profit 0.10
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.08
    EBITDA 0.10
    Effective Tax Rate (%) 0.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 0.11
    Operating Expense 0.08
    Net Profit 0.02
    Net Profit Margin (%) 18.18
    Earnings Per Share (EPS) 0.02
    EBITDA 0.02
    Effective Tax Rate (%) 0.00
    Particulars MAR 2008 (Values in Cr)
    Book Value / Share 5.64
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.42
    EBITDA Margin -3.61
    Particulars MAR 2007 (Values in Cr)
    Book Value / Share 7.23
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.41
    EBITDA Margin -0.40
    Particulars MAR 2006 (Values in Cr)
    Book Value / Share 7.94
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.21
    EBITDA Margin -5.76
    Particulars MAR 2005 (Values in Cr)
    Book Value / Share 9.57
    ROE % 3.45
    ROCE % 6.33
    Total Debt to Total Equity 0.15
    EBITDA Margin 4.42
    Particulars MAR 2004 (Values in Cr)
    Book Value / Share 9.47
    ROE % 2.79
    ROCE % 5.32
    Total Debt to Total Equity 0.24
    EBITDA Margin 3.05
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 9.12
    ROE % 3.81
    ROCE % 2.42
    Total Debt to Total Equity 1.19
    EBITDA Margin 11.73
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 1.00
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 1.13
    ROE % 0.62
    ROCE % 0.62
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 0.08
    ROE % 0.16
    ROCE % 0.16
    Total Debt to Total Equity 0.00
    EBITDA Margin 18.18
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 0.06
    ROE % 0.98
    ROCE % 0.98
    Total Debt to Total Equity 0.00
    EBITDA Margin 46.15
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.12
    Total Assets 266.97
    Total Liabilities 266.97
    Total Equity 102.51
    Share Outstanding 11
    Price to Book Ratio 1.00
    Return on Assets (%) 0.81
    Return on Capital (%) 0.96
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 1.37
    Total Liabilities 1.37
    Total Equity 1.34
    Share Outstanding 1
    Price to Book Ratio 3.76
    Return on Assets (%) -12.75
    Return on Capital (%) -13.04
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.00
    Total Assets 1.52
    Total Liabilities 1.52
    Total Equity 1.51
    Share Outstanding 1
    Price to Book Ratio 3.56
    Return on Assets (%) 6.65
    Return on Capital (%) 6.71
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.06
    Total Assets 0.09
    Total Liabilities 0.09
    Total Equity 0.09
    Share Outstanding 1
    Price to Book Ratio 122.13
    Return on Assets (%) 24.35
    Return on Capital (%) 25.35
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.04
    Total Assets 0.07
    Total Liabilities 0.07
    Total Equity 0.06
    Share Outstanding 1
    Price to Book Ratio 31.33
    Return on Assets (%) 75.52
    Return on Capital (%) 79.44
    Particulars MAR 2025 (Values in Cr)
    Net Income 2.78
    Cash from Operations -222.02
    Cash from Investing -0.06
    Cash from Financing 222.19
    Net change in Cash 0.10
    Free Cash Flow -222.01
    Particulars MAR 2024 (Values in Cr)
    Net Income -0.17
    Cash from Operations -0.12
    Cash from Investing 0.16
    Cash from Financing -0.01
    Net change in Cash 0.02
    Free Cash Flow -0.12
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.10
    Cash from Operations 0.10
    Cash from Investing 0.00
    Cash from Financing -0.17
    Net change in Cash -0.06
    Free Cash Flow 0.10
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.02
    Cash from Operations 0.01
    Cash from Investing 0.00
    Cash from Financing 0.00
    Net change in Cash 0.01
    Free Cash Flow 0.01
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.05
    Cash from Operations 0.04
    Cash from Investing 0.00
    Cash from Financing 0.00
    Net change in Cash 0.04
    Free Cash Flow 0.04
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AEGIS LOGISTICS LIMITED 1349.40 54.90 7.82 47363.94 576.00 1434.00
    KOTHARI INDUSTRIAL CORP L 162.75 0.00 8.39 1758.05 142.00 624.95
    OSWAL AGRO MILLS LTD. 37.23 0.00 0.55 499.74 33.50 94.50
    DHUNSERI VENTURES LIMITED 243.97 9.38 0.25 854.38 186.99 386.00
    RAMA PETROCHEMICALS LTD. 15.20 0.00 -0.37 23.44 12.05 16.92
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AEGIS LOGISTICS LIMITED 1349.40 51.02 13.69 47363.94 576.00 1434.00
    UTIQUE ENTERPRISES LIMITED 3.80 11.18 0.29 21.16 3.20 6.40
    COMPUTER POINT LTD. 3.55 0.00 0.31 10.65 3.26 5.98
    FGP LTD. 10.69 178.17 3.72 12.72 7.32 12.75

    WELCURE DRUGS & PHARMACEUTICAL shareholding pattern

    Holding
    100.0%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    WELCURE DRUGS & PHARMACEUTICAL Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    0.25 0.00 redarrow
    red-green-graph indicator
    14 Bearish
    2 Bullish
    • 5 Days 0.20
    • 26 Days 0.30
    • 10 Days 0.30
    • 50 Days 0.30
    • 12 Days 0.30
    • 100 Days 0.30
    • 20 Days 0.30
    • 200 Days 0.40
    0.25 PIVOT
    First Support 0.24 First Resistance 0.25 Second Support 0.24 Second Resistance 0.26 Third Support 0.23 Third Resistance 0.26
    RSI 45.62 ADX 11.40 MACD -0.01 Williams % R -50.00 Commodity Channel Index (CCI) -169.08
    Date 2026-07-24 Week 2790235.00 Same Day 3294151.00 Month 2614973.00
    1 Year 1.26 3 Year 0.81
    Over 1 Month
    -7.40% down
    Over 1 Year
    -72.82% down
    Over 3 Months
    -16.66% down
    Over 3 Years
    -9.74% down
    Over 6 Months
    -26.47% down
    Over 5 Years
    -14.89% down

    WELCURE DRUGS & PHARMACEUTICAL Corporate Actions

    Ex-Date Ex-Bonus Ratio
    16 Oct 2025 16 Oct 2025 1:10
    Ex-Date Old FV NEW FV Record Date
    16 Oct 2025 10.0 1.0 16 Oct 2025

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Welcure Drugs & Pharmaceuticals Ltd?

    Answer Field

    Welcure Drugs & Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 0.25 as on Jul 24 2026 03:29 PM.

    What is the Market Cap of Welcure Drugs & Pharmaceuticals Ltd Share?

    Answer Field

    The market cap of Welcure Drugs & Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 30.90 as on Jul 24 2026 03:29 PM.

    What is the 52 Week High and Low of Welcure Drugs & Pharmaceuticals Ltd?

    Answer Field

    The 52 Week High and Low of Welcure Drugs & Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1.18 and ₹ 0.23.

    What is 1 year return for Welcure Drugs & Pharmaceuticals Ltd?

    Answer Field

    The 1 year returns on the stock has been -72.82%.

    What is the P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 24 2026 03:29 PM the price-to-earnings (PE) ratio for Welcure Drugs & Pharmaceuticals Ltd share is -6.25.

    What is the PB ratio of Welcure Drugs & Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 24 2026 03:29 PM, the price-to-book (PB) ratio for Welcure Drugs & Pharmaceuticals Ltd share is 0.78.

    How to Buy Welcure Drugs & Pharmaceuticals Ltd Share?

    Answer Field

    You can trade in Welcure Drugs & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Welcure Drugs & Pharmaceuticals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Welcure Drugs & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Welcure Drugs & Pharmaceuticals Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |